Exapto is a company headquartered in France.
Exapto engineers bacterial strains and a synthetic biology platform to convert biosourced feedstocks (e.g., methanol, sugar, agricultural residues) into chemical building blocks identical to petroleum-derived molecules. It supplies industrial clients with ready-to-use strains and step-by-step fermentation protocols to enable lower-carbon chemical production.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.